Fulgent Genetics, Inc. - stock earnings
FLGT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -128.1 million USD | 70.5 million USD |
| 2023Q3 | -13.1 million USD | 84.7 million USD |
| 2023Q2 | -11.2 million USD | 67.9 million USD |
| 2023Q1 | -15.8 million USD | 66.2 million USD |
| 2022Q4 | -24.1 million USD | 67.7 million USD |
| 2022Q3 | 1.3 million USD | 105.7 million USD |
| 2022Q2 | 11.5 million USD | 125.3 million USD |
| 2022Q1 | 154.0 million USD | 320.3 million USD |
| 2021Q4 | 104.3 million USD | 251.7 million USD |
| 2021Q3 | 122.5 million USD | 227.9 million USD |
| 2021Q2 | 79.8 million USD | 153.6 million USD |
| 2021Q1 | 200.7 million USD | 359.4 million USD |
| 2020Q4 | 166.3 million USD | 295.0 million USD |
| 2020Q3 | 46.6 million USD | 101.7 million USD |
| 2020Q2 | 3.3 million USD | 17.3 million USD |
| 2020Q1 | -2.0 million USD | 7.8 million USD |
| 2019Q4 | -296000 USD | 8.4 million USD |
| 2019Q3 | 1.5 million USD | 10.3 million USD |
| 2019Q2 | 331000 USD | 8.4 million USD |
| 2019Q1 | -1.9 million USD | 5.4 million USD |
| 2018Q4 | -935000 USD | 5.7 million USD |
| 2018Q3 | -595000 USD | 5.6 million USD |
| 2018Q2 | -1.0 million USD | 5.4 million USD |
| 2018Q1 | -1.9 million USD | 4.7 million USD |
| 2017Q4 | -1.8 million USD | 4.3 million USD |
| 2017Q3 | -1.1 million USD | 4.5 million USD |
| 2017Q2 | -25000 USD | 4.6 million USD |
| 2017Q1 | 232000 USD | 5.3 million USD |
| 2016Q4 | 813000 USD | 5.9 million USD |
| 2016Q3 | -1.0 million USD | 5.0 million USD |
| 2016Q2 | -4.5 million USD | 4.0 million USD |
| 2016Q1 | -543000 USD | 3.4 million USD |
| 2015Q4 | -8.5 million USD | 2.9 million USD |
| 2015Q3 | 359000 USD | 2.9 million USD |
| 2015Q2 | 98000 USD | 2.2 million USD |
| 2015Q1 | ? USD | 1.6 million USD |
FLGT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -167.8 million USD | 289.2 million USD |
| 2022 | 143.4 million USD | 619.0 million USD |
| 2021 | 104.3 million USD | 992.6 million USD |
| 2020 | 214.3 million USD | 421.7 million USD |
| 2019 | 366000 USD | 32.5 million USD |
| 2018 | -4.5 million USD | 21.4 million USD |
| 2017 | -2.7 million USD | 18.7 million USD |
| 2016 | -5.4 million USD | 18.3 million USD |
| 2015 | -8.3 million USD | 9.6 million USD |
| 2014 | -4.3 million USD | 1.3 million USD |
FLGT
Price: $20.10
52 week price:
Earnings Per Share: -5.63 USD
P/E Ratio: -11.69
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 235500
Ebitda: -1.0 millionMarket Capitalization: 633.8 million